India needs to diversify its pharma-centric portfolio and innovate more (The Economic Times)

India is becoming an ‘innovation destination’, according to Nasscom chairman R Chandrasekaran. Really? Patent grants are a straightforward indicator of innovative capability. India has registered a seven-year decline in patents granted and a concurrent rise in applications. This gap signifies the deterioration in the quality and legitimacy of India’s innovations in independent estimates.

http://blogs.economictimes.indiatimes.com/et-commentary/india-needs-to-diversify-its-pharma-centric-portfolio-and-innovate-more/

“India needs to diversify its pharma-centric portfolio and innovate more.” Economic Times (India), 8 July 2015, with Asit K. Biswas.